NCT07005154 A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer Status RECRUITING Phase PHASE2
NCT06983821 Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW) Status RECRUITING Phase PHASE3
NCT06977711 Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL) Status RECRUITING Phase PHASE1
NCT06954805 Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD) Status RECRUITING Phase PHASE2
NCT06934915 Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder Status RECRUITING Phase EARLY_PHASE1
NCT06925737 A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) Status RECRUITING Phase PHASE3
NCT06904599 Efficacy of Human Chorionic Gonadotropin in Acute GVHD Treatment Status RECRUITING Phase PHASE2
NCT06890884 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011) Status RECRUITING Phase PHASE2
NCT06860243 A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009) Status COMPLETED Phase PHASE1
NCT06833814 DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations Status NOT_YET_RECRUITING Phase PHASE4
NCT06833411 Treatment for Giant Cell Arteritis With Tocilizumab and 8 as Compared to 26 Weeks of Prednisone Status NOT_YET_RECRUITING Phase PHASE3
NCT06814132 A Study to Evaluate the Effect of MK-5684 in Male Participants With Severe Renal Impairment (RI) and With End-stage Renal Disease (ESRD) (MK-5684-010) Status COMPLETED Phase PHASE1
NCT06803693 Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL Status RECRUITING Phase PHASE2
NCT06789315 Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis Status NOT_YET_RECRUITING Phase NA
NCT06756061 Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity Status RECRUITING Phase PHASE2
NCT06738368 Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT06730542 Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma Status RECRUITING Phase PHASE1
NCT06717347 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010) Status RECRUITING Phase PHASE3
NCT06704555 Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma Status RECRUITING Phase PHASE2